Target Name: CD302
NCBI ID: G9936
Review Report on CD302 Target / Biomarker Content of Review Report on CD302 Target / Biomarker
CD302
Other Name(s): CD302 molecule | CD302_HUMAN | DEC205-associated C-type lectin 1 | C-type lectin domain family 13 member A | CD302 antigen (isoform 1) | type I transmembrane C-type lectin receptor DCL-1 | OTTHUMP00000205017 | DCL1 | DCL-1 | FLJ43091 | BIMLEC | MGC22301 | CD302 antigen | C-type lectin BIMLEC | KIAA0022 | C-type lectin domain family 13, member A | CLEC13A | CD302 variant 1 | CD302 molecule, transcript variant 1 | Type I transmembrane C-type lectin receptor DCL-1

CD302: A Promising Drug Target and Biomarker

Introduction

CD302 is a protein that is expressed in various tissues of the human body, including the immune system, and it plays a crucial role in cell signaling and immune responses. Despite its importance, CD302 has not yet been identified as a drug target or biomarker, which leaves room for research in the field. In this article, we will explore the CD302 molecule, its functions, potential drug targets, and its potential as a biomarker in various diseases.

CD302 Molecule and Its Functions

CD302 is a type-I transmembrane protein that is composed of 214 amino acids. It has a molecular weight of 31 kDa and a calculated pI of 6.5. CD302 is expressed in various tissues of the human body, including the skin, lung, heart, liver, and spleen. It is involved in the immune response, cell signaling, and tissue repair.

One of the most significant functions of CD302 is its role in the immune response. CD302 is a key regulator of the T cell receptor, which is responsible for cell signaling and the development of immune responses. CD302 helps regulate the interactions between T cells and other immune cells, ensuring that T cells recognize and respond to foreign antigens in the body.

In addition to its role in immune regulation, CD302 is also involved in cell signaling. It has been shown to play a role in the regulation of cell adhesion, migration, and survival. CD302 has also been shown to promote the growth and differentiation of various cell types, including cancer cells.

Potential Drug Targets

CD302's involvement in cell signaling makes it an attractive drug target. Several studies have identified potential drug targets for CD302, including the inhibition of CD302-mediated signaling pathways, the modulation of CD302 expression, and the use of small molecules or antibodies to interact with CD302.

One of the most promising potential drug targets for CD302 is the inhibition of its downstream signaling pathway, which includes the PI3K/Akt signaling pathway. This pathway is involved in various cellular processes, including cell survival, angiogenesis, and inflammation. inhibiting CD302-mediated Signaling through small molecules or antibodies has the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

CD302 as a Biomarker

CD302 has the potential to serve as a biomarker for several diseases. Its involvement in the immune response and cell signaling makes it an attractive biomarker for diseases that are characterized by inflammation or cellular dysfunction.

One of the most promising applications of CD302 as a biomarker is its use in cancer diagnosis and treatment. Cancer is characterized by the activation and proliferation of cells that have lost normal growth and differentiation control. The immune response is often impaired in cancer, making it difficult to diagnose and treat the disease. CD302 has been shown to be expressed in various types of cancer, including breast, lung, and ovarian cancer. Therefore, its levels can be used as a biomarker for cancer diagnosis and treatment.

In addition to its use in cancer diagnosis and treatment, CD302 has the potential to serve as a biomarker for other diseases, including neurodegenerative diseases and autoimmune diseases. Its involvement in the immune response and cell signaling makes it an attractive biomarker for these diseases, as the immune response is often impaired in these conditions.

Conclusion

CD302 is a protein that is involved in various functions of the immune system and cell signaling. Its potential as a drug target and biomarker makes it an attractive target for further research in the field. Further studies are needed to understand its full role in

Protein Name: CD302 Molecule

Functions: Potential multifunctional C-type lectin receptor that may play roles in endocytosis and phagocytosis as well as in cell adhesion and migration

The "CD302 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD302 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8